The inquiry examines whether the company improperly disclosed private health information to third-party advertisers. Legal counsel is also reviewing claims regarding deceptive billing practices and assertions that the platform deliberately obstructed customers attempting to cancel their subscriptions. These allegations suggest a failure by the board to uphold its obligations to both the company and its investors.
Hims & Hers operates a direct-to-consumer platform connecting users with licensed healthcare providers for prescription services. Berger Montague, a firm with a history of high-stakes class action litigation, has invited shareholders to provide information regarding their experiences. Interested parties are directed to contact firm representatives Andrew Abramowitz or Caitlin Adorni to discuss potential legal recourse.





Comments (0)
No comments yet. Be the first!